Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1286 NOK | +1.90% | -1.53% | -53.74% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 493M 46.33M |
---|---|---|---|---|---|
Net income 2024 * | -195M -18.31M | Net income 2025 * | -234M -21.98M | EV / Sales 2024 * | - |
Net Debt 2024 * | 70.86M 6.66M | Net Debt 2025 * | 284M 26.66M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.74
x | P/E ratio 2025 * |
-1.5
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.97% |
Latest transcript on BerGenBio ASA
1 day | +1.90% | ||
1 week | -1.53% | ||
Current month | -11.31% | ||
1 month | -18.09% | ||
3 months | -43.60% | ||
6 months | -15.39% | ||
Current year | -53.74% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Olin
CEO | Chief Executive Officer | 55 | 21-09-07 |
Rune Skeie
DFI | Director of Finance/CFO | 51 | 18-03-04 |
Cristina Oliva
CTO | Chief Tech/Sci/R&D Officer | - | 22-04-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sally Bennett
BRD | Director/Board Member | 52 | 20-12-08 |
Sveinung Hole
BRD | Director/Board Member | 57 | 10-08-31 |
Chairman | 63 | 22-01-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 0.1286 | +1.90% | 26 033 676 |
24-05-22 | 0.1262 | -3.81% | 27,518,500 |
24-05-21 | 0.1312 | +0.46% | 45,311,520 |
24-05-16 | 0.1306 | +4.48% | 28,785,130 |
24-05-15 | 0.125 | +2.29% | 26,800,110 |
Real-time Oslo Bors, May 23, 2024 at 06:20 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.74% | 46.16M | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-1.08% | 21.97B | |
-5.34% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- BGBIO Stock